Stock listing
Natera, Inc.
- Ticker
- Frankfurt:45E
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Natera, Inc.
FDA Grants Breakthrough Device Designation for Natera’s Multi-Cancer Early Detection Assay
Oct 9, 2026
Natera Announces Randomized, Signatera™-Guided Interventional Study in Melanoma
Oct 7, 2026
New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists
Oct 6, 2026
Alliance Foundation Trials and Natera Announce AFT-70 NAVIGATE: a Global, Randomized, Phase III Trial Evaluating Genentech’s Oral Selective Estrogen Receptor Degrader (SERD) with Signatera™ MRD-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Oct 5, 2026